To date, extracellular vesicles (EVs) have been extensively investigated as potential
substitutes for cell therapy. Research has suggested their ability to overcome serious risks …

Exosomes are cell‐derived extracellular vesicles of 40–160 nm diameter, which carry
numerous biomolecules and transmit information between cells. They are used as functional …

Extracellular vesicles (EVs) occur in a variety of bodily fluids and have gained recent
attraction as natural materials due to their bioactive surfaces, internal cargo, and role in …

In the last few decades, the practical use of stem cells (SCs) in the clinic has attracted
significant attention in the regenerative medicine due to the ability of these cells to proliferate …

Extracellular vesicles (EVs) are cornerstones of intercellular communication with exciting
fundamental, clinical, and more broadly biotechnological applications. However, variability …

Extracellular vesicles (EVs) are cell‐secreted biological nanoparticles that are critical
mediators of intercellular communication. They contain diverse bioactive components, which …

Cancer continues to pose a global threat despite potent anticancer drugs, often
accompanied by undesired side effects. To enhance patient outcomes, sophisticated …

Biomimetic delivery systems (BDSs), inspired by the intricate designs of biological systems,
have emerged as a groundbreaking paradigm in nanomedicine, offering unparalleled …

Extracellular vesicles (EVs) are implicated as promising therapeutics and drug delivery
vehicles in various diseases. However, successful clinical translation will depend on the …

With the immense progress in drug delivery systems (DDS) and the rise of nanotechnology,
challenges such as target specificity remain. The vesicle-vector system (VVS) is a delivery …